The United Laboratories International Holdings Limited

中/EN
中文繁體 English
  • Investor Relations
    IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
  • Corporate
Investor Relations
  • IR Home
  • Corporate Overview
  • Financial Highlights
  • Financial Reports
  • ESG Reports
  • Regulatory Filings
  • Press Releases
  • Company
    Presentations
  • Stock Quotes &
    Charts
  • Analyst Coverage
  • FAQs
  • IR Contact

Latest News

JUL
10
FDA APPROVAL OF IND FOR UBT37034 INJECTION
JUL
02
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2025
JUN
30
Special dividend for the year ended 31 December 2024

2024

Annual Report
PDF | eBook

ESG Report 2024

  • Environment
  • Social
  • Governance

Presentation

Investor Information

  • Regulatory Filings
  • Corporate Governance
  • Stock Quotes & Charts
  • FAQs

IR Contact

6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong
tulir@tul.com.hk
Disclaimer | Sitemap

Copyright © 2019 The United Laboratories International Holdings Limited. All rights reserved.